These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10482480)

  • 1. Ciclosporin microemulsion preconcentrate treatment of patients with Behçet's disease.
    Fujino Y; Joko S; Masuda K; Yagi I; Kogure M; Sakai J; Usui M; Kotake S; Matsuda H; Ikeda E; Mochizuki M; Nakamura S; Ohno S
    Jpn J Ophthalmol; 1999; 43(4):318-26. PubMed ID: 10482480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of malignant rhabdoid tumor in a patient with Behçet's disease treated with ciclosporin.
    Muramatsu M; Kotake S; Yoshikawa K; Sasamoto Y; Matsuda H; Yamawaki S
    Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):798-9. PubMed ID: 9801898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taskintuna I; Firat E
    Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial hemorrhage in neuro-Behçet's syndrome.
    Kikuchi S; Niino M; Shinpo K; Terae S; Tashiro K
    Intern Med; 2002 Sep; 41(9):692-5. PubMed ID: 12322793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ciclosporin-associated cerebral tumor-like location of Behçet's disease].
    Bouomrani S; Hammami S; Braham R; Mahjoub S
    Rev Neurol (Paris); 2010 Oct; 166(10):849-54. PubMed ID: 20346476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
    Atmaca LS; Batioğlu F
    Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
    Tugal-Tutkun I; Kadayifcilar S; Khairallah M; Lee SC; Ozdal P; Özyazgan Y; Song JH; Yu HG; Lehner V; de Cordoue A; Bernard O; Gül A
    Ocul Immunol Inflamm; 2017 Feb; 25(1):62-70. PubMed ID: 26829647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.
    Margreiter R;
    Lancet; 2002 Mar; 359(9308):741-6. PubMed ID: 11888584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease.
    Chatterjee A; D'Souza RJ
    Nephrol Dial Transplant; 1997 Dec; 12(12):2799-800. PubMed ID: 9430907
    [No Abstract]   [Full Text] [Related]  

  • 14. Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.
    Kato Y; Numaga J; Kato S; Kaburaki T; Kawashima H; Fujino Y
    Clin Exp Ophthalmol; 2001 Oct; 29(5):335-6. PubMed ID: 11720163
    [No Abstract]   [Full Text] [Related]  

  • 15. SER recommendations on treatment of refractory Behçet's syndrome.
    Moriano Morales C; Graña Gil J; Brito García N; Martín Varillas JL; Calvo Del Río V; Moya Alvarado P; Narváez García FJ; Espinosa G; Díaz Del Campo Fontecha P; Guerra Rodríguez M; Mateo Arranz J; López Gómez M; Francisco Hernández FM; Trujillo MM; Dos Santos Sobrín R; Martín Sánchez JI; Maese Manzano J; Suárez Cuba J
    Reumatol Clin (Engl Ed); 2024 Apr; 20(4):204-217. PubMed ID: 38614885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
    Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.